医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

乳腺核磁共振简易序列在乳腺肿瘤筛查中的应用价值

A study of a breast MRI abbreviated protocol for breast neoplasm screening

摘要目的:评价乳腺核磁共振(MRI)简易序列(AP)对乳腺肿瘤的诊断准确性。方法:回顾性分析86例乳腺MRI检查,采用AP和常规序列(FDP)两种检查方法对图像进行对比分析,AP 包括轴位T2加权成像(T2-weighted imaging,T2WI)、扩散加权成像(diffuion-weighted imaging,DWI)和动态增强4期图像,FDP包括矢状位T2WI、轴位T1加权成像(T1-weighted imaging,T1WI)、T2WI、DWI和动态增强7期图像。根据乳腺影像报告和数据系统标准(breast imaging reporting and data system,BI-RADS)各自诊断并比较两者的一致性,再以病理结果为标准比较两种序列对乳腺肿瘤的诊断效能。结果:2位医师独立阅片时,相同医师在不同序列间通过BI-RADS分类的诊断一致性为0.856、0.900,通过时间信号强度曲线(time-signal intensity curve,TIC)类型的诊断一致性为0.822、0.922,差异均无统计学意义( P>0.05);相同序列在不同医师间通过BI-RADS分类的诊断一致性为0.744、0.822,通过TIC类型的诊断一致性为0.889、0.878,差异均无统计学意义( P>0.05)。2位医师共同阅片,AP和FDP诊断恶性肿瘤在BI-RADS分类的敏感度分别为89.8%(95 %CI:0.785~0.958)、91.5%(95 %CI:0.806~0.968),特异度为71.0%(95 %CI:0.518~0.851)、77.4%(95 %CI:0.585~0.897),曲线下面积为0.804(95 %CI:0.698~0.910)、0.845(95 %CI:0.748~0.941);两种序列诊断恶性肿瘤在TIC类型的敏感度分别为86.4%(95 %CI:0.745~0.936)、89.8%(95 %CI:0.785~0.958),特异度为61.3%(95 %CI:0.423~0.776)、67.7%(95 %CI:0.485~0.827),曲线下面积为0.739(95 %CI:0.623~0.855)、0.788(95 %CI:0.679~0.897),以上差异均无统计学意义( P>0.05)。AP和FDP的扫描时间分别为(11.97±0.94)min、(21.25±1.12)min,差异有统计学意义( P<0.001)。AP的平均阅片时间较FDP减少13.5%。 结论:与FDP相比,采用AP可缩短乳腺MRI扫描时间并能保持诊断效能,可作为高危人群乳腺肿瘤MRI筛查的改进模式。

更多

abstractsObjective:This study aimed to evaluate the performance of breast magnetic resonance imaging (MRI) abbreviated protocol (AP) in diagnosing breast neoplasms.Methods:We retrospectively analyzed the data of 86 patients who had undergone breast MRI examinations and compared the images using an AP and full diagnostic protocol (FDP). The AP consisted of axial T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and four-phase dynamic enhancement sequences. The FDP consisted of sagittal T2WI, axial T2WI, T1-weighted imaging, DWI, and seven-phase dynamic enhancement sequences. All the images were analyzed using the Breast Imaging Reporting and Data System (BI-RADS). The consistencies between the different protocols were then calculated. With the pathological diagnosis as the gold standard, the diagnostic capabilities of the two protocols were compared.Result:Two radiologists analyzed the AP and FDP images. The consistencies in the BI-RADS between the different protocols were 0.856 and 0.900, and those in time-signal intensity curves (TICs) were 0.822 and 0.922. Within the same protocol, the consistencies in the BI-RADS between different radiologists were 0.744 and 0.822, and those in TICs were 0.889 and 0.878. No significant differences were found ( P>0.05). In terms of diagnosing malignant neoplasms using the BI-RADS, the sensitivities of the AP and FDP were 89.8% (95 %CI: 0.785-0.958) and 91.5% (95 %CI: 0.806-0.968), respectively; their specificities were 71.0% (95 %CI: 0.518-0.851) and 77.4% (95 %CI: 0.585-0.897), respectively; and the areas under the curves (AUCs) were 0.804 (95 %CI: 0.698-0.910) and 0.845 (95 %CI: 0.748-0.941), respectively. Diagnosing malignant neoplasms using TICs, the sensitivities of the AP and FDP were 86.4% (95 %CI: 0.745-0.936) and 89.8% (95 %CI: 0.785-0.958), respectively; their specificities were 61.3% (95 %CI: 0.423-0.776) and 67.7% (95 %CI: 0.485-0.827), respectively, and the AUCs were 0.739 (95 %CI: 0.623-0.855) and 0.788 (95 %CI: 0.679-0.897), respectively. There was no significant difference between the AP and FDP ( P>0.05). The MRI acquisition times of the AP and FDP were 11.97±0.94 min and 21.25±1.12 min, respectively, with a significant difference ( P<0.001). The average reading time was reduced by 13.5% using the AP compared with that using the FDP. Conclusion:Compared with the FDP, the AP reduced the acquisition time and maintained the diagnostic accuracy, which can be used as an improved pattern for MRI screening in high-risk populations of breast neoplasms.

More
广告
  • 浏览268
  • 下载120
中华健康管理学杂志

中华健康管理学杂志

2020年14卷2期

160-164页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷